Education symposium in March 2020 in Chicago

Great opportunity to learn more about Crohn’s and Colitis!

The Crohn’s and Colitis Foundation (formerly CCFA or Crohn’s and Colitis Foundation of America) is divided into statewide chapters. The Illinois Chapter has been a well respoected chapter and historically has run some of the best educational programs in the country for years.

The next Educational Symposium is coming in 2020, specifically March 14, 2020. It will be held at the Hyatt Regency O’Hare hotel. This is in Rosemont, a Chicago Suburb next to O’Hare.

There are two symposiums running in parallel: A patient centered symposium and a medical professional symposium.

Annual Patient/Professional Education Symposium
Hyatt Regency O’Hare
9300 W Bryn Mawr Ave
Rosemont, IL 60018

To register click on this link to the Registration Website. But this is a tease, you’ll have to sign up in January 2020 when the registration information will be available.

In the mean time, the Carol Fisher chapter has a load of activities to articipate in. Check out their website!

Health Recommendations for IBD Patients

Patients with Crohn’s and Colitis need their doctors when they are sick, but what should be done when they are well?

So, you have IBD, either Crohn’s disease or ulcerative colitis. Your doctor has worked with you to deal with your underlying disease. What should you do between flares of disease and long term?

Gastroenterologists think of their patients in several ways. One major way to think about our patients is what are we doing for treatment of the disease and what are we doing for general medical care. Gastroenterologists are specialists in digestive disease. But all gastroenterologists first are trained in internal medicine before getting the additional training to become a gastroenterologist.

An article in the April 2019 issue of Clinical Gastroenterology and Hepatology had a nice review of preventive care for patients with IBD. The recommendations fall into two broad categories: Screening Recommendations and Recommendations for follow up for certain drugs.

Screening Recommendations

Screenings are done to prevent certain problems that affect IBD patients more often related to risks due to the underlying disease and due to treatments.

Immunizations in IBD include the usual recommendations. Special attention is due to Influenza, pneumonia, and shingles. Flu shots with injected vaccine is recommended. The live virus nasal vaccine should be avoided. Pneumococcal vaccine should be given to all IBD patients on immunosuppression, shich is pretty much everything except mesalamine related drugs. Shingles vaccine is recommended for IBD patients over age 50. All IBD patients should get the HPV vaccine.

Skin cancer risk is increased in individuals on Anti-TNF drugs, azathioprine, 6-MP, and tofacitinib. Routine use of sunscreen and protective colthing is advised. Acute sunburn is more common on steroids as well, due to photosensitization. Consultation with a dermatologist is suggested.

Exercise is recommended for all patients to decrease the risk of osteoporosis. Calcium and Vitamin D should be checked and supplemented as appropriate. The paper says that about 1000 IU of vitamin D is needed. I believe the paper is incorrect here. Vitamin D is usually low in patients and a dose of 5000 IU of cholecalciferol is needed to keep the level over 4000 ng/dl in most patients.

Patients have an increased risk of colon cancer. Colonosocpy is recommeded in patients with over 30% of their colons involved with IBD after 8 years of disease or sooner if other family risk factors are present. If sclerosing cholangitis is present then colonoscopy should be done as soon as practicable.

Women on immunosupression should get yearly PAP smears.

Patients on steroids for more than 3 months should get a DEXA scan for checking bone mineral density. (Budesonide and rectal steroids are not as risky.)

Recommendations for follow up for certain drugs

Certain drugs need specific follow ups.

Drug Tests Notes
MesalamineCBC
Creatinine
UA
Allergic nephritis can develop. Check every 3-6 months.
ThiopurinesCBC
LFTs
Check TPMT before starting if available to identify patients.
MethotrexateCBC
Creatinine
LFTs
At start, weeks 2, 4, 8 then every 1-3 months. Give folic acid. Chest x-ray at 6-12 months.
TofacitinibCBC
LFTs
Lipid Panel
TB test
Hepatitis B
Check labs every 3 months. Check lipid panel at 4-6 months. Check TB test at start and 2 months into treatment. Get Hepatitis B tests before starting.
BiologicsCBC
Creatinine
LFTs
TB test
Hepatitis B
Get TB and hepatitis B tests before start. Check for TB twice a year in high risk patients. Get Hepatitis B tests before starting.

Final Thoughts

You can bring this to your doctor or send the reference to the article that I have provided below. Also, do your part and show up to see your doctor. He can’t do his part if you don’t do your’s!

References

  • Weaver KN1, Long MD2. Preventive Medicine in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 Apr;17(5):824-828. PMID: 30529728.

Probiotics May Change Without Your Knowing

Readily available in stores and pharmacies, probiotics are a popular product that people take thinking they are good for your health. But if you buy a product you should expect it to remain unchanged over time. A recent article discusses the problem that probiotics are not regulated.

Probiotics are a polular product used by millions and big business, too. These products promise improved health, but at the same time don’t make health claims. I have a real problem with these products, because the cost my patients money but I don’t see them gettting benefit.

A major problem I see is that since they come in pill form people imagine they are like medical pills. However, each brand has different bacteria or groups of bacteria. We don’t know if probiotics work due to the surface structures on the germs or if there are metabolites that bacteria make that affect health, so it isn’t relly even known if the probiotics need to be alive or dead.

Another major problem is you don’t know what you’re getting even from time to time that you get a probiotic. It’s been known that in the growing of bacteria the bacteria can change over time. An article in by Claudio de Simone from the University of L ‘Aquila published in Clinical Gastroenterology and Hepatology(1) is worth a read as it discusses a number of points regarding the problem of probiotics not being regulated.

The following snippet from the article is from figure 2 in the article. Phosphatidylglycerols are an important part of bacterial cell membranes and the ratios of these are characteristic of different types of bacteria. If two bacteria are the same their PG ratios will be the same. In this example a probiotic was analyzed that was sold in the US and Italy. As can be seen, the Italian version of the probiotic had a different PG content then the US version, even though thew were sold as the same product.



One has to conclude that these products have different bacteria in them. It is a concern that may probotic products have differing bacteial content from year to year or batch to batch.

Another important point is that with many IBD patients having leaky gut that these probiotics are introducing to new bacteria in patients who could have those bacteria wander across their intestinal surface into the tissues. Given that we don’t have good safety data in IBD patients with this products and that the products also change what is in them over time I wouln’t recommend these products to patients.

References

  • de Simone C1. The Unregulated Probiotic Market. Clin Gastroenterol Hepatol. 2019 Apr;17(5):809-817. PMID: 29378309.